✦ LIBER ✦

Should Minimal Residual Disease Monitoring in Acute Lymphoblastic Leukemia be Standard of Care?

✍ Scribed by Dario Campana

Book ID: 111653230
Publisher: Current Science Inc.
Year: 2012
Tongue: English
Weight: 178 KB
Volume: 7
Category: Article
ISSN: 1558-8211
DOI: 10.1007/s11899-012-0115-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Minimal Residual Disease in Acute Lympho

Minimal Residual Disease in Acute Lymphoblastic Leukemia

✍ Dario Campana 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 41 KB

Acute Lymphoblastic Leukemia: Monitoring

Acute Lymphoblastic Leukemia: Monitoring Minimal Residual Disease as a Therapeutic Principle

✍ Monika Brüggemann; Nicola Gökbuget; Michael Kneba 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 509 KB

Role of Minimal Residual Disease Monitor

Role of Minimal Residual Disease Monitoring in Adult and Pediatric Acute Lymphoblastic Leukemia

✍ Campana, Dario 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 422 KB

Minimal residual disease quantification

Minimal residual disease quantification in adult acute lymphoblastic leukemia

✍ Heather Landau; Mark A. Weiss 📂 Article 📅 2006 🏛 Current Science Inc. 🌐 English ⚖ 61 KB

Detection of minimal residual disease in

Detection of minimal residual disease in pediatric acute lymphoblastic leukemia

✍ Gaipa, Giuseppe; Basso, Giuseppe; Biondi, Andrea; Campana, Dario 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 623 KB

Monitoring of minimal residual disease i

Monitoring of minimal residual disease in acute myeloid leukemia

✍ Wolfgang Kern; Claudia Haferlach; Torsten Haferlach; Susanne Schnittger 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 587 KB

## Abstract Two highly sensitive methods, multiparameter flow cytometry (MFC) and real‐time quantitative PCR (RQ‐PCR), are increasingly used to monitor minimal residual disease (MRD) and to guide risk‐adapted management in acute myeloid leukemia (AML). An independent prognostic impact has been demo